ARCHIVES

Centers, Groups, Others May Land in DeVita’s Office; Hammer Offers Deal congress Can’t Refuse

This article is from The Cancer Letter archive.

Vol. 14 No. 06 | February 5, 1988

Download PDF Visit The Full Archive

Related Articles

Preliminary Report Tends To Support Pill’s Association With Liver Tumors

November 19, 1976

Lapatinib Improves Outcome Of Advanced Breast Cancer

July 28, 2006

Canadian Products Anticancer Drugs In Plant Culture

April 22, 1983

New Safety Concerns On ESAs Prompt FDA To Consult ODAC Again.

January 11, 2008

FDA Approves Abraxane For Second-Line Treatment Of Metastatic Breast Cancer

January 28, 2005

FDA Updates Safety Information for 5-Alpha Reductase Inhibitors

June 17, 2011